Literature DB >> 6661034

Effect of interferon on the penetration of murine leukemia virus and the binding of its genome RNA to polyribosomes at the early stage of infection.

S Salzberg, R Shurtz, J Feder, M Aboud.   

Abstract

The effect of interferon (IFN) on the adsorption, penetration and subsequent binding of the incoming genome RNA of Moloney murine leukemia virus (MLV) to polyribosomes, was studied in NIH/3T3 mouse fibroblasts. Virus adsorption was assayed by determining reverse transcriptase activity in the inoculating virus stock and in the cell membrane fraction before and after 45 minutes of infection. Both measurements suggested that IFN had no effect on virus adsorption. Virus penetration was determined by measuring the amount of viral RNA in the cell cytoplasm at 45 minutes after infection. This amount was remarkably lower in IFN-treated than in untreated cells. This reduction was not due to inhibition of a possible induction of endogenous viral genetic information by the penetrating virions, but was proved to be a direct effect of IFN on virus penetration, which was related to the IFN-induced antiviral state. The effect of IFN on binding of parental genome RNA to polyribosomes was then investigated by analysing Crt hybridization kinetics of polyribosomal viral RNA at different time intervals after infection. While in untreated control cells maximal binding occurred at 3 hours postinfection, this maximal binding was observed in IFN-treated cells at 5 hours postinfection. The distribution of viral RNA molecules between sub-cytoplasmic fractions at 3 hours after infection was, in IFN-treated cells, significantly different from that observed in the untreated cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661034     DOI: 10.1007/bf01311321

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Infectious viral DNA of murine leukemia virus.

Authors:  D Smotkin; A M Gianni; S Rozenblatt; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Synthesis of the precursor to avian RNA tumor virus internal structural proteins early after infection.

Authors:  B M Gallis; R N Eisenman; H Diggelmann
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

3.  Isolation and characterization of DNA-DNA and DNA-RNA.

Authors:  S Salzberg; Z Levi; M Aboud; A Goldberger
Journal:  Biochemistry       Date:  1977-01-11       Impact factor: 3.162

4.  Adsorption, penetration, and uncoating of murine leukemia virus studied by using its reverse transcriptase.

Authors:  M Aboud; R Shoor; S Salzberg
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

5.  Interferon inhibits transformation by murine sarcoma viruses before integration of provirus.

Authors:  R J Avery; J D Norton; J S Jones; D C Burke; A G Morris
Journal:  Nature       Date:  1980-11-06       Impact factor: 49.962

6.  A large glycoprotein of Moloney leukemia virus derived from interferon-treated cells.

Authors:  E H Chang; R M Friedman
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

7.  Effect of interferon on exogenous murine leukemia virus infection.

Authors:  M Aboud; R Shoor; S Salzberg
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

8.  An interferon-sensitive early step in the establishment of infection of murine cells by murine sarcoma/leukaemia virus.

Authors:  A G Morris; D C Burke
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

9.  Evidence for a cytoplasmic factor regulating murine leukemia virus DNA synthesis and its preliminary characterization.

Authors:  M Aboud; A Dank-Nudel; R Shurtz; S Salzberg
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Properties of mouse leukemia viruses. VII. The major viral glycoprotein of friend leukemia virus. Isolation and physicochemical properties.

Authors:  V Moennig; H Frank; G Hunsmann; I Schneider; W Schafer
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.